The laboratory test procedure to confirm rotavirus vaccine infection in severe complex immunodeficiency patients

The rotavirus vaccine is a live vaccine, and there is a possibility of infection by the virus strain used in the vaccine. We investigated the process of determining whether an infection was caused by the vaccine strain in a severe complex immunodeficiency (SCID) patient with rotavirus infection. The...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Su-Jin Chae, Seung-Rye Cho, Wooyoung Choi, Myung-Guk Han, Deog-Yong Lee
Formato: article
Lenguaje:EN
Publicado: Korea Centers for Disease Control & Prevention 2021
Materias:
Acceso en línea:https://doaj.org/article/b8223bfb2e024d58b2baa630e58b76fb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b8223bfb2e024d58b2baa630e58b76fb
record_format dspace
spelling oai:doaj.org-article:b8223bfb2e024d58b2baa630e58b76fb2021-11-05T00:06:00ZThe laboratory test procedure to confirm rotavirus vaccine infection in severe complex immunodeficiency patients2210-90992210-911010.24171/j.phrp.2021.0079https://doaj.org/article/b8223bfb2e024d58b2baa630e58b76fb2021-08-01T00:00:00Zhttp://ophrp.org/upload/pdf/j-phrp-2021-0079.pdfhttps://doaj.org/toc/2210-9099https://doaj.org/toc/2210-9110The rotavirus vaccine is a live vaccine, and there is a possibility of infection by the virus strain used in the vaccine. We investigated the process of determining whether an infection was caused by the vaccine strain in a severe complex immunodeficiency (SCID) patient with rotavirus infection. The patient was vaccinated with RotaTeq prior to being diagnosed with SCID. The testing process was conducted in the following order: confirming rotavirus infection, determining its genotype, and confirming the vaccine strain. Rotavirus infection was confirmed through enzyme immunoassay and VP6 gene detection. G1 and P[8] were identified by multiplex polymerase chain reaction for the genotype, and G3 was further identified using a single primer. By detecting the fingerprint gene (WC3) of RotaTeq, it was confirmed that the detected virus was the vaccine strain. Genotypes G1 and P[8] were identified, and the infection was suspected of having been caused by rotavirus G1P[8]. G1P[8] is the most commonly detected genotype worldwide and is not included in the recombinant strains used in vaccines. Therefore, the infection was confirmed to have been caused by the vaccine strain by analyzing the genetic relationship between VP4 and VP7. Rotavirus infection by the vaccine strain can be identified through genotyping and fingerprint gene detection. However, genetic linkage analysis will also help to identify vaccine strains.Su-Jin ChaeSeung-Rye ChoWooyoung ChoiMyung-Guk HanDeog-Yong LeeKorea Centers for Disease Control & Preventionarticleinfantile diarrhealaboratory testrotavirus infectionsrotavirus vaccinessevere combined immunodeficiencySpecial situations and conditionsRC952-1245Infectious and parasitic diseasesRC109-216ENOsong Public Health and Research Perspectives, Vol 12, Iss 4, Pp 269-273 (2021)
institution DOAJ
collection DOAJ
language EN
topic infantile diarrhea
laboratory test
rotavirus infections
rotavirus vaccines
severe combined immunodeficiency
Special situations and conditions
RC952-1245
Infectious and parasitic diseases
RC109-216
spellingShingle infantile diarrhea
laboratory test
rotavirus infections
rotavirus vaccines
severe combined immunodeficiency
Special situations and conditions
RC952-1245
Infectious and parasitic diseases
RC109-216
Su-Jin Chae
Seung-Rye Cho
Wooyoung Choi
Myung-Guk Han
Deog-Yong Lee
The laboratory test procedure to confirm rotavirus vaccine infection in severe complex immunodeficiency patients
description The rotavirus vaccine is a live vaccine, and there is a possibility of infection by the virus strain used in the vaccine. We investigated the process of determining whether an infection was caused by the vaccine strain in a severe complex immunodeficiency (SCID) patient with rotavirus infection. The patient was vaccinated with RotaTeq prior to being diagnosed with SCID. The testing process was conducted in the following order: confirming rotavirus infection, determining its genotype, and confirming the vaccine strain. Rotavirus infection was confirmed through enzyme immunoassay and VP6 gene detection. G1 and P[8] were identified by multiplex polymerase chain reaction for the genotype, and G3 was further identified using a single primer. By detecting the fingerprint gene (WC3) of RotaTeq, it was confirmed that the detected virus was the vaccine strain. Genotypes G1 and P[8] were identified, and the infection was suspected of having been caused by rotavirus G1P[8]. G1P[8] is the most commonly detected genotype worldwide and is not included in the recombinant strains used in vaccines. Therefore, the infection was confirmed to have been caused by the vaccine strain by analyzing the genetic relationship between VP4 and VP7. Rotavirus infection by the vaccine strain can be identified through genotyping and fingerprint gene detection. However, genetic linkage analysis will also help to identify vaccine strains.
format article
author Su-Jin Chae
Seung-Rye Cho
Wooyoung Choi
Myung-Guk Han
Deog-Yong Lee
author_facet Su-Jin Chae
Seung-Rye Cho
Wooyoung Choi
Myung-Guk Han
Deog-Yong Lee
author_sort Su-Jin Chae
title The laboratory test procedure to confirm rotavirus vaccine infection in severe complex immunodeficiency patients
title_short The laboratory test procedure to confirm rotavirus vaccine infection in severe complex immunodeficiency patients
title_full The laboratory test procedure to confirm rotavirus vaccine infection in severe complex immunodeficiency patients
title_fullStr The laboratory test procedure to confirm rotavirus vaccine infection in severe complex immunodeficiency patients
title_full_unstemmed The laboratory test procedure to confirm rotavirus vaccine infection in severe complex immunodeficiency patients
title_sort laboratory test procedure to confirm rotavirus vaccine infection in severe complex immunodeficiency patients
publisher Korea Centers for Disease Control & Prevention
publishDate 2021
url https://doaj.org/article/b8223bfb2e024d58b2baa630e58b76fb
work_keys_str_mv AT sujinchae thelaboratorytestproceduretoconfirmrotavirusvaccineinfectioninseverecompleximmunodeficiencypatients
AT seungryecho thelaboratorytestproceduretoconfirmrotavirusvaccineinfectioninseverecompleximmunodeficiencypatients
AT wooyoungchoi thelaboratorytestproceduretoconfirmrotavirusvaccineinfectioninseverecompleximmunodeficiencypatients
AT myunggukhan thelaboratorytestproceduretoconfirmrotavirusvaccineinfectioninseverecompleximmunodeficiencypatients
AT deogyonglee thelaboratorytestproceduretoconfirmrotavirusvaccineinfectioninseverecompleximmunodeficiencypatients
AT sujinchae laboratorytestproceduretoconfirmrotavirusvaccineinfectioninseverecompleximmunodeficiencypatients
AT seungryecho laboratorytestproceduretoconfirmrotavirusvaccineinfectioninseverecompleximmunodeficiencypatients
AT wooyoungchoi laboratorytestproceduretoconfirmrotavirusvaccineinfectioninseverecompleximmunodeficiencypatients
AT myunggukhan laboratorytestproceduretoconfirmrotavirusvaccineinfectioninseverecompleximmunodeficiencypatients
AT deogyonglee laboratorytestproceduretoconfirmrotavirusvaccineinfectioninseverecompleximmunodeficiencypatients
_version_ 1718444551401635840